Jeffrey Schwartz - 16 Mar 2023 Form 4 Insider Report for SpringWorks Therapeutics, Inc. (SWTX)

Role: Director
Signature: /s/ Jeffrey Schwartz
Issuer symbol: SWTX
Transactions as of: 16 Mar 2023
Transactions value $: -$49,875,000
Form type: 4
Filing time: 20 Mar 2023, 17:00:14 UTC
Previous filing: 10 Jun 2022
Next filing: 05 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SWTX	Common Stock	Sale	-$49.9M	-1.75M	-36.22%	$28.50	3.08M	16 Mar 2023	See footnote	F1
holding	SWTX	Common Stock						5.92K	16 Mar 2023	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of shares of common stock held directly by BC SW, LP. Bain Capital Life Sciences Investors, LLC ("BCLSI") is the general partner of BC SW, LP. Mr. Schwartz is a Partner of BCLSI. As a result, Mr. Schwartz may be deemed to share voting and dispositive power with respect to the shares of common stock held by BC SW, LP. Mr. Schwartz disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Content

Consists of shares of common stock held directly by BC SW, LP. Bain Capital Life Sciences Investors, LLC ("BCLSI") is the general partner of BC SW, LP. Mr. Schwartz is a Partner of BCLSI. As a result, Mr. Schwartz may be deemed to share voting and dispositive power with respect to the shares of common stock held by BC SW, LP. Mr. Schwartz disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.